Synexa Life Sciences celebrates its 20th anniversary

Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights.

March 3, 2023

Synexa Life Sciences to appoint Chief Commercial Officer to support company growth ambitions

Leading specialist biomarker and bioanalysis solutions provider further strengthens global management team.

August 19, 2022

Synexa Life Sciences expands operations in North America with new Rockville laboratory site

New site supports unique and seamless workflows that narrow the gap between preclinical and clinical phases

June 13, 2022

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals.

May 19, 2022

Synexa Life Sciences announces strategic growth plans and strengthening of its executive team

Delivering on growth strategies to become the global market leader in specialist biomarker and bioanalytical services.

May 18, 2022

Synexa Life Sciences Co-founder and CEO to become company’s Chairman

Leading biomarker and bioanalysis company lays the foundation for future growth and expansion plan.

May 13, 2022